Comments
Loading...
Guidance e previsioni
Jazz Pharmaceuticals fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/05/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | $4.80 | $5.60 | $3.76 | $4.15B | $4.30B | $4.24B | |
05/06/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | $20.50 | $22.10 | $23.23 | $4.15B | $4.40B | $4.29B | |
02/25/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | $22.50 | $24.00 | $24.00 | $4.15B | $4.40B | $4.34B | |
01/13/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | — | — | — | $4.00B | $4.10B | $4.04B | |
12/16/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | — | — | — | $4.00B | $4.10B | $4.04B | |
11/06/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $19.50 | $20.60 | $19.59 | $4.00B | $4.10B | $4.04B | |
07/31/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $19.20 | $20.30 | $18.51 | $4.00B | $4.10B | $4.05B | |
05/01/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $18.15 | $19.35 | $18.93 | $4.00B | $4.20B | $4.10B | |
02/28/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $18.15 | $19.35 | $19.94 | $4.00B | $4.20B | $4.09B | |
01/08/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | — | — | — | $3.81B | $3.81B | $3.83B | |
01/08/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | — | — | — | $5.00B | $5.00B | — | |
11/08/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $18.15 | $19.00 | $18.66 | $3.75B | $3.88B | $3.83B | |
08/09/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $18.15 | $19.00 | $17.48 | $3.73B | $3.88B | $3.78B | |
05/10/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $16.90 | $17.85 | $17.44 | $3.67B | $3.88B | $3.78B | |
03/01/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $16.90 | $17.85 | $18.00 | $3.67B | $3.88B | $3.76B | |
11/09/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $17.20 | $17.85 | $17.41 | $3.60B | $3.70B | $3.65B | |
08/03/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $16.70 | $17.70 | $17.09 | $3.50B | $3.70B | $3.60B | |
05/04/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | — | — | — | $3.50B | $3.70B | $3.58B | |
03/01/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $16.00 | $17.00 | $17.47 | $3.46B | $3.66B | $3.64B | |
01/10/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | — | — | — | $3.02B | $3.10B | $3.07B | |
11/09/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.10 | $15.80 | $14.52 | $3.02B | $3.10B | $3.09B | |
08/03/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $13.40 | $14.70 | $14.45 | $3.02B | $3.18B | $3.11B | |
06/17/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $13.40 | $14.70 | $15.05 | $3.02B | $3.18B | $3.11B | |
05/04/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.65 | $16.86 | $16.39 | $2.55B | $2.70B | $2.65B | |
04/20/2021 | JAZZ | Jazz Pharmaceuticals | Q1 | 2021 | — | — | — | $605.00M | $610.00M | $613.95M | |
02/23/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.65 | $16.85 | $16.78 | $2.55B | $2.70B | $2.56B |
FAQ
Qual è la guidance più recente per Jazz Pharmaceuticals (JAZZ)?
Le ultime previsioni per Jazz Pharmaceuticals (JAZZ) sono state riportate il agosto 5, 2025 per l'intero anno 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $4.80 a $5.60, rispetto all'EPS stimato di $3.76. Inoltre, Jazz Pharmaceuticals ha previsto ricavi tra $4.15B e $4.30B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.